Synergy Pharma Cash Flow - Annual (NASDAQ:SGYP)

Add to My Stocks
$1.71 $0.02 (1.18%) SGYP stock closing price Sep 19, 2018 (Closing)

For analyzing any company like Synergy Pharma from an investment perspective, its important to check the cash flow statement. The profit-loss statement shows Synergy Pharma profits, the balance sheet shows Synergy Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Items like capital purchases, bank loan payments etc. which have a direct impact on the cash position of a company come out through the statemement of cash flows and help an investor who undertakes the Synergy Pharma stock analysis. Synergy Pharma generated $-212.88M cash from operating activities in 2017. SGYP decrease in investments stood at a value of $-0.21M for the latest year 2017.

View details of Synergy Pharma cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow1.5M7.15M4.62M---0.08M----
Net Increase (Decrease) in Assets Liabilities-13M6.62M1.7M2.62M4.91M3.95M-2.33M3.34M-1.42M1.33M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net22.94M55.07M10.18M3.36M4.46M4.45M-4.43M-1.05M28.53M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.21M-0.29M-0.05M-0.17M-0.61M-0.02M----0.01M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments-50.09M-0.2M--30M-20M----
Other Cash Inflow (Outflow) from Investment Activities-----0.27M-1.76M--0.7M-0.28M-0.85M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares174.14M101.39M16.82M33.96M94.85M55.86M34.78M7.17M15.97M2.95M
Issuance (Repayment) of Debt Securities95.14M--200M------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-1.59M-0.71M-0.4M-16.83M-5.62M-3.77M-2.14M-0.46M-0.26M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year82.38M61.65M146.47M18.13M12.41M13.24M1.7M7.15M--
Cash & Equivalents at Year End136.98M82.38M61.65M146.47M18.13M12.41M13.24M1.7M7.15M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Synergy Pharma stock price history provides insight into historical stock price fluctuations, and Synergy Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Synergy Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Synergy Pharma stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-212.88M for SGYP.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.21M for SGYP in last 2017 report.
  • Cash flow from financing activities shows the flow of cash between Synergy Pharma and its owners and creditors and was $267.69M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Synergy Pharma Cash Flow